New clinical trial software version provides direct data capture at investigator sites
New clinical trial software version provides direct data capture at investigator sites
Velos, Inc. (Fremont, CA) has released Velos eResearch Version 7 for increased features and functions for large investigative sites. Velos eResearch is a clinical trial management software system.
Velos eResearch Version 7 provides direct capture of clinical trial data, eliminating duplicate data entry. This in turn allows the systems used at the site to generate better or higher quality research data, and offer improved efficiency and productivity for investigators and sponsors.
Velos eResearch 7 uses Web 2.0 technology and system design. It features HL7 compliance, support for study administration, clinical data management, adverse event reporting, compliance with industry standards (including CFR Part 11), patient- and study-level architecture, and advanced security to large multi-institutional clinical studies.
Velos, Inc., (510) 739-4010, www.velos.com
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Regulatory Compliance With eCOAs
April 26th 2024In the fourth and final part of this video interview with ACT editor Andy Studna, Melissa Mooney, director, eCOA sales engineering, IQVIA discusses how the regulatory stance on electronic clinical outcome assessments has changed over the years and what it could look like in the future.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.
Using Patient Reported Outcomes in Dermatology Trials
April 25th 2024In part 3 of this video interview with ACT editor Andy Studna, Melissa Mooney, director, eCOA sales engineering, IQVIA sheds light on the unique challenges of dermatology trials and how clinical outcome assessments can be implemented in them.